Correlation of inflammatory and cardiovascular biomarkers with pneumonia severity scores;Correlación entre los niveles de biomarcadores inflamatorios y cardiovasculares con los índices de severidad de neumonía

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 32, Issue 3, 2014, Pages 140-146

  Lacoma, Alicia ^a,b   Bas, Albert ^a   Tudela, Pere ^a   Giménez, Montse ^a   Mòdol, Josep Maria ^a   Pérez, Miguel ^a   Ausina, Vicente ^a,b   Dominguez, Jose ^a,b   Prat Aymerich, Cristina ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Biomarkers; Pneumonia; Prognosis; Severity scores

Indexed keywords

ADRENOMEDULLIN; ATRIAL NATRIURETIC FACTOR; C REACTIVE PROTEIN; NEOPTERIN; PROCALCITONIN; BIOLOGICAL MARKER; MID REGIONAL PROADRENOMEDULLIN; MID REGIONAL PROATRIAL NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; PROADRENOMEDULLIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL PNEUMONIA; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CORRELATION ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HIGH RISK POPULATION; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PLEURA EFFUSION; PROGNOSIS; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS MITIS; STREPTOCOCCUS PNEUMONIAE; CONFUSION UREA RESPIRATORY RATE BLOOD PRESSURE AND AGE 65 SCORE; CONTROLLED STUDY; DISEASE ASSESSMENT; HIGH RISK PATIENT; HOSPITAL ADMISSION; INTENSIVE CARE UNIT; PNEUMONIA; PNEUMONIA SEVERITY INDEX; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE ASSESSMENT; SCORING SYSTEM; SEVERE COMMUNITY ACQUIRED PNEUMONIA SCORE; SHOCK; SMART COP SCORE; BLOOD; CARDIOVASCULAR DISEASE; INFLAMMATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INFLAMMATION; MALE; PNEUMONIA, BACTERIAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 84896716640     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2013.07.006     Document Type: Article

References (46)

1. M.J. Fine, T.E. Auble, D.M. Yealy, B.H. Hanusa, L.A. Weissfeld, and D.E. Singer et al. A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 1997 243 250
2. W.S. Lim, M.M. van der Eerden, R. Laing, W.G. Boersma, N. Karalus, and G.I. Town et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 58 2003 377 382
3. P.P. España, A. Capelastegui, J.M. Quintana, A. Bilbao, R. Diez, and S. Pascual et al. Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia J Infect 60 2010 106 113
4. M. Falcone, S. Corrao, M. Venditti, P. Serra, and G. Licata Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia Intern Emerg Med 6 2011 431 436
5. P.P. España, A. Capelastegui, I. Gorordo, C. Esteban, M. Oribe, and M. Ortega et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia Am J Respir Crit Care Med 174 2006 1249 1256
6. P.G. Charles, R. Wolfe, M. Whitby, M.J. Fine, A.J. Fuller, and R. Stirling et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia Clin Infect Dis 47 2008 375 384
7. C. Marti, N. Garin, O. Grosgurin, A. Poncet, C. Combescure, and S. Carballo et al. Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis Crit Care 16 2012 R141
8. J.D. Chalmers, A. Singanayagam, and A.T. Hill Predicting the need for mechanical ventilation and/or inotropic support for young adults admitted to the hospital with community-acquired pneumonia Clin Infect Dis 47 2008 1571 1574
9. A. Lacoma, C. Prat, and V. Ausina Importance of biomarkers in diagnosis, prognosis and new therapies in infectious diseases Enferm Infecc Microbiol Clin 28 2010 263 265
10. C. Prat, J. Dominguez, F. Andreo, S. Blanco, A. Pallares, and F. Cuchillo et al. Procalcitonin and neopterin correlation with aetiology and severity of pneumonia J Infect 52 2006 169 177
11. J. Almirall, I. Bolibar, P. Toran, G. Pera, X. Boquet, and X. Balanzo et al. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia Chest 125 2004 1335 1342
12. M. Christ-Crain, P. Schuetz, and B. Muller Biomarkers in the management of pneumonia Expert Rev Respir Med 2 2008 565 572
13. P. Schuetz, A. Litke, W.C. Albrich, and B. Mueller Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia Curr Opin Infect Dis 26 2013 159 167
14. J.P. Hinson, S. Kapas, and D.M. Smith Adrenomedullin, a multifunctional regulatory peptide Endocr Rev 21 2000 138 167
15. R. Witthaut Science review: natriuretic peptides in critical illness Crit Care 8 2004 342 349
16. N.G. Morgenthaler, J. Struck, B. Thomas, and A. Bergmann Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma Clin Chem 50 2004 234 236
17. N.G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay Clin Chem 51 2005 1823 1829
18. C. Prat, A. Lacoma, J. Dominguez, J. Papassotiriou, N.G. Morgenthaler, and F. Andreo et al. Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia J Infect 55 2007 400 407
19. A. Lacoma, C. Prat, F. Andreo, L. Lores, I. Latorre, and M. Pérez et al. Usefulness of mid regional pro-atrial natriuretic peptide in the exacerbations of chronic obstructive pulmonary disease Clin Chim Acta 412 2011 470 475
20. D. Stolz, M. Christ-Crain, N.G. Morgenthaler, D. Miedinger, J. Leuppi, and C. Muller et al. Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD Chest 134 2008 263 272
21. S. Kruger, S. Ewig, S. Giersdorf, O. Hartmann, N. Suttorp, and T. Welte Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: results from the German Competence Network, CAPNETZ Am J Respir Crit Care Med 182 2010 1426 1434
22. A. Lacoma, C. Prat, F. Andreo, and J. Dominguez Biomarkers in the management of COPD Eur Respir Rev 18 2009 96 104
23. C. Courtais, N. Kuster, A.M. Dupuy, M. Folschveiller, R. Jreige, and A.S. Bargnoux et al. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia Am J Emerg Med 31 2013 215 221
24. W.C. Albrich, F. Dusemund, K. Ruegger, M. Christ-Crain, W. Zimmerli, and T. Bregenzer et al. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm BMC Infect Dis 11 2011 112
25. B. Renaud, P. Schuetz, Y.E. Claessens, J. Labarere, W. Albrich, and B. Mueller Proadrenomedullin improves risk of early admission to ICU score for predicting early severe community-acquired pneumonia Chest 142 2012 1447 1454
26. M. Christ-Crain, and B. Muller Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators Eur Respir J 30 2007 556 573
27. L.A. Mandell, R.G. Wunderink, A. Anzueto, J.G. Bartlett, G.D. Campbell, and N.C. Dean et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 Suppl. 2 2007 S27 S72
28. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
29. R.P. Dellinger, J.M. Carlet, H. Masur, H. Gerlach, T. Calandra, and J. Cohen et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Crit Care Med 32 2004 858 873
30. J. Dominguez, N. Gali, S. Blanco, P. Pedroso, C. Prat, and L. Matas et al. Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples Chest 119 2001 243 249
31. F. Andreo, J. Ruiz-Manzano, C. Prat, L. Lores, S. Blanco, and A. Malet et al. Utility of pneumococcal urinary antigen detection in diagnosing exacerbations in COPD patients Respir Med 104 2010 397 403
32. J.D. Coonrod, and M.W. Rytel Detection of type-specific pneumococcal antigens by counterimmunoelectrophoresis. I. Methodology and immunologic properties of pneumococcal antigens J Lab Clin Med 81 1973 770 777
33. P. Tudela, J.M. Modol, M.J. Rego, M. Bonet, B. Vilaseca, and J. Tor Diagnosis mistake in the emergency room: relation to main symptom at admission, reasons and clinical implications Med Clin (Barc) 125 2005 366 370
34. P. Tudela, C. Prat, A. Lacoma, J.M. Modol, J. Dominguez, and M. Gimenez et al. Biomarcadores para la predicción en urgencias de infección bacteriana, bacteriemia y gravedad Emergencias 24 2012 348 356
35. R. Menendez, R. Martinez, S. Reyes, J. Mensa, X. Filella, and M.A. Marcos et al. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia Thorax 64 2009 587 591
36. M. Christ-Crain, N.G. Morgenthaler, D. Stolz, C. Muller, R. Bingisser, and S. Harbarth et al. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397] Crit Care 10 2006 R96
37. D.T. Huang, D.C. Angus, J.A. Kellum, N.A. Pugh, L.A. Weissfeld, and J. Struck et al. Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia Chest 136 2009 823 831
38. P. Tudela, A. Lacoma, C. Prat, J. Modol, M. Gimenez, and J. Barallat et al. Prediction of bacteremia in patients with suspicion of infection in emergency room Med Clin 135 2010 685 690
39. F. Muller, M. Christ-Crain, T. Bregenzer, M. Krause, W. Zimmerli, and B. Mueller et al. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial Chest 138 2010 121 129
40. M. Christ-Crain, N.G. Morgenthaler, J. Struck, S. Harbarth, A. Bergmann, and B. Muller Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study Crit Care 9 2005 R816 R824
41. M. Sogaard, M. Norgaard, L. Pedersen, H.T. Sorensen, and H.C. Schonheyder Blood culture status and mortality among patients with suspected community-acquired bacteremia: a population-based cohort study BMC Infect Dis 11 2011 139
42. K.L. Becker, E.S. Nylen, J.C. White, B. Muller, and R.H. Snider Jr. Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors J Clin Endocrinol Metab 89 2004 1512 1525
43. L. Simon, F. Gauvin, D.K. Amre, P. Saint-Louis, and J. Lacroix Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis Clin Infect Dis 39 2004 206 217
44. B. Muller, and C. Prat Markers of acute inflammation in assessing and managing lower respiratory tract infections: focus on procalcitonin Clin Microbiol Infect 12 Suppl. 9 2006 8 16
45. M. Christ-Crain, D. Jaccard-Stolz, R. Bingisser, M.M. Gencay, P.R. Huber, and M. Tamm et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial Lancet 363 2004 600 607
46. E. Zudaire, S. Portal-Nunez, and F. Cuttitta The central role of adrenomedullin in host defense J Leukoc Biol 80 2006 237 244